Tejani AD, Rembold CM. Force augmentation and stimulated actin polymerization in swine carotid artery. Am J Physiol Cell Physiol 298: C182-C190, 2010. First published October 14, 2009 doi:10.1152/ajpcell.00326.2009.-The phenomenon of posttetanic potentiation, in which a single submaximal contraction or series of submaximal contractions strengthens a subsequent contraction, has been observed in both skeletal and cardiac muscle. In this study, we describe a similar phenomenon in swine carotid arterial smooth muscle. We find that a submaximal K ϩ depolarization increases the force generation of a subsequent maximal K ϩ depolarization; we term this "force augmentation." Force augmentation was not associated with a significant increase in crossbridge phosphorylation or shortening velocity during the maximal K ϩ depolarization, suggesting that the augmented force was not caused by higher crossbridge phosphorylation or crossbridge cycling rates. We found that the characteristics of the tissue before the maximal K ϩ depolarization predicted the degree of force augmentation. Specifically, measures of stimulated actin polymerization (higher prior Y118 paxillin phosphorylation, higher prior F-actin, and transition to a more solid rheology evidenced by lower noise temperature, hysteresivity, and phase angle) predicted the subsequent force augmentation. Increased prior contraction alone did not induce force augmentation since readdition of Ca 2ϩ to Ca 2ϩ -depleted tissues induced a partial contraction that was not associated with changes in noise temperature or with subsequent force augmentation. These data suggest that stimulated actin polymerization may produce a substrate for increased crossbridge mediated force, a process we observe as force augmentation. phase angle; noise temperature; paxillin; rheology; vascular smooth muscle IN SKELETAL AND CARDIAC MUSCLE, a single submaximal contraction resulting from a single action potential is referred to as a twitch, and the sustained contraction resulting from repetitive action potentials is referred to as tetanus. In both skeletal and cardiac muscle, both twitches and submaximal tetany will potentiate a subsequent contraction induced by maximal tetany, a phenomenon termed posttetanic potentiation. Skeletal muscle posttetanic potentiation is thought to be caused by crossbridge phosphorylation (31). In this study, we describe a similar phenomenon in arterial smooth muscle in which a submaximal K ϩ contraction increases the maximum force of a subsequent maximal K ϩ contraction, a phenomenon we term "force augmentation." We find, however, that force augmentation in smooth muscle is associated with stimulated actin polymerization and not by increased crossbridge phosphorylation or shortening velocity.
IN SKELETAL AND CARDIAC MUSCLE, a single submaximal contraction resulting from a single action potential is referred to as a twitch, and the sustained contraction resulting from repetitive action potentials is referred to as tetanus. In both skeletal and cardiac muscle, both twitches and submaximal tetany will potentiate a subsequent contraction induced by maximal tetany, a phenomenon termed posttetanic potentiation. Skeletal muscle posttetanic potentiation is thought to be caused by crossbridge phosphorylation (31) . In this study, we describe a similar phenomenon in arterial smooth muscle in which a submaximal K ϩ contraction increases the maximum force of a subsequent maximal K ϩ contraction, a phenomenon we term "force augmentation." We find, however, that force augmentation in smooth muscle is associated with stimulated actin polymerization and not by increased crossbridge phosphorylation or shortening velocity.
It is widely accepted that most forms of arterial smooth muscle contraction primarily involve increased myoplasmic calcium ([Ca 2ϩ ] i ), which increases crossbridge phosphorylation on Ser 19 of the myosin regulatory light chain (MRLC) via MRLC kinase (reviewed in Ref. 15) . Contractile agonistinduced inhibition of MRLC phosphatase can also increase crossbridge phosphorylation and therefore participate in smooth muscle contraction (4, 29) . Increases in crossbridge phosphorylation are felt to be the primary regulator of contractile force (10, 17, 27) .
Recent data suggest that crossbridge phosphorylation is not the only regulator of contractile force. Several groups found that smooth muscle contraction was associated with increases in paxillin tyrosine phosphorylation and actin polymerization (2, 13, 14, 16) , a phenomenon we term "stimulated actin polymerization." We found that the sustained phase of swine carotid artery contraction was associated with 1) increased Y118 paxillin phosphorylation, 2) increased actin polymerization as measured by an increase in F-actin content, and 3) transition to a more solid rheology, as evidenced by reductions in the mechanical measurements noise temperature, hysteresivity, and phase angle (25) . The time course of Y118 paxillin phosphorylation, actin polymerization, and transition to a solid rheology was slower than the time course of contraction, suggesting that 1) the initial phase of contraction was caused by increased crossbridge phosphorylation and not by stimulated actin polymerization and that 2) stimulated actin polymerization could be responsible for force maintenance with reduced crossbridge phosphorylation during the sustained phase of contraction, i.e., the latch phenomenon (3, 20) .
Smooth muscle cells have "solid-like" stiffness but have the structural disorder of a liquid. As such smooth muscle cells can be described by the theory of "soft glassy rheology" (8) .
Glasslike stiffness results from the interaction of neighboring molecules that are trapped in a metastable configuration. This metastable configuration can be altered by movement of any molecule, which causes secondary rearrangement of the configuration of the system. The measures noise temperature, hysteresivity, and phase angle are rheologic measures of whether the cell behaves more like a Hookean elastic solid or a Newtonian viscous fluid. A Hookean elastic solid (with no rearrangements) is characterized by a noise temperature of 1, a hysteresivity of 0, and a phase angle of 0 (11) . A Newtonian viscous fluid (with frequent rearrangement) is characterized by a noise temperature of 2, high hysteresivity, and high phase angle. Smooth muscle contraction is associated with changes in tissue rheology (1, 11) . We found that stimulus-induced increases in Y118 paxillin phosphorylation and actin polymerization during the sustained phase of the contraction were associated with transition to a more solid rheology as measured by decreases in noise temperature, hysteresivity, and phase angle (25) .
We hypothesized that stimulus-induced increases in Y118 paxillin phosphorylation, actin polymerization, and changes in tissue rheology could be responsible for force augmentation, in which submaximal activation increases the force of a subsequent maximal contraction. In this study, we first describe the phenomenon of force augmentation and then evaluate whether stimulated actin polymerization could be responsible for force augmentation.
MATERIALS AND METHODS
Tissues. Physiological saline solution (PSS) contained (in mM) 140 NaCl, 4.7 KCl, 2 3-(N-morpholino)propanesulfonic acid (MOPS), 1.2 Na2HPO4, 1.6 CaCl2, 1.2 MgSO4, 5.6 D-glucose, and 0.02 EDTA, pH adjusted to 7.4 at 37°C. Swine common carotid arteries were obtained from an abattoir and dissected, and the endothelium was removed, mounted as rings for biochemical assays or in aluminum foil clips for mechanical assays, bathed in physiological saline at 37°C, and set at Lo, the optimal length for force development, as described (21, 25) . Setting length at Lo involved two conditioning contractions with 109 mM K ϩ PSS where KCl was substituted stoichiometrically for NaCl. Forces were normalized to tissue cross-sectional areas and therefore are presented as stress in units of 10 5 N/m 2 . Biochemical measurements. Y118 paxillin phosphorylation, crossbridge (Ser 19 -MRLC) phosphorylation, and F-actin content was determined in two sets of swine common carotid artery rings mounted isometrically at 1.0 Lo and contracted with identical protocols.
To measure Y119 paxillin and crossbridge phosphorylation, one set of tissues was frozen after appropriate treatment in acetone dry ice, and homogenized in 1% SDS, 10% glycerol (vol/vol), and 20 mM dithiothreitol (0.22 ml/mg tissue dry wt) as described (25) . The level of Y118 paxillin phosphorylation was determined by loading tissue homogenates on two 10% SDS electrophoresis gels followed by immunoblotting on polyvinylidene difluoride membranes for total paxillin and Y118 phosphorylated paxillin (25) . Phosphorylation for each ring was calculated as the ratio of Y118 phosphorylated paxillin to total paxillin immunostaining. Phosphorylation for each ring was then normalized to the level of Y118 phosphorylation in the unstimulated control with the control value ϭ 1.0. The amount of force augmentation was determined in these tissues before freezing, so comparison of force augmentation with biochemical characteristics could be done in individual tissues (see Fig. 5 ).
The level of crossbridge (Ser 19 -MRLC) phosphorylation was determined in the same homogenates by isoelectric focusing and immunoblotting as described (24) . Three dilutions of homogenates were loaded to ensure that the enhanced chemiluminescence detection system was in the linear range (23) . Phosphorylation is reported as mol Pi/mol protein.
To measure relative F-actin content, a second set of swine common carotid artery rings was frozen after appropriate treatment with liquid N 2-chilled tongs. The relative amount of filamentous actin (F-actin) versus total actin was determined with a commercial kit (BK037) from Cytoskeleton (Denver, CO) as previously described (12, 25) . The amount of force augmentation was not determined in these tissues, so mean force augmentation in similarly treated tissues (from the paxillin measurements) was compared with mean F-actin data in Fig. 5 .
Noise temperature, hysteresivity, phase angle, stiffness, and shortening velocity measurements. Noise temperature, hysteresivity, phase angle, and stiffness (GЈ) were measured in a third set of tissues as described (25) . Both ends of swine carotid tissue strips were mounted in 1.2 mm diameter aluminum foil cylinders with cyanoacrylate glue. One cylinder was attached to an adjustable length stationary rod and the other cylinder to the lever arm of an Aurora Scientific model 310B dual mode lever operated by Dynamic Muscle Control software (Aurora Scientific, Aurora, ON, Canada). After setting tissue length to L o as described above, tissues were treated pharmacologically and at various times oscillated with sine wave changes in length (0.5% Lo at 0.3, 1, 3, 10, and 30 Hz) and the resulting change in force was measured [these changes in force can be seen in Fig. 3 (5, 6) ]. Force values were normalized as stress values (force per cross-sectional area in N/m 2 ). The real part of stiffness (GЈ) was calculated as the peak-to-peak change in stress observed with 10-Hz oscillations (this was valid because calculated phase angles were all Ͻ10°, i.e., cos 10°ϭ ϳ1). Noise temperature was calculated as 1 ϩ [the least squares regression slope of ln real stiffness (GЈ) as a function of ln oscillation frequency].
For the experiment shown in Fig. 2 , shortening velocity was measured in tissues mounted as above for noise temperature measurement. After equilibration, each tissue was stimulated with 109 mM K ϩ for 10 min with releases at 1 and 10 min, followed by 25 mM K ϩ for 30 min with releases at 12 and 21 min, and a second 109 mM K ϩ for 10 min with releases at 1 and 10 min (3, 20) . Releases were performed to loads of 10% and 40% in a random order (percent loads were those entered into the Dynamic Muscle Control software), and velocity was calculated as change in length vs. time from 1 to 2 s after release as described (18) . Statistical analysis. Unless otherwise noted, all values are reported as means Ϯ SE. Statistical significance testing was performed by Fisher least significant difference test post ANOVA (SigmaStat, Systat Software, Richmond, CA), with P Ͻ 0.05 as the criterion for significance. Figure 1 shows the experiment in which we first discovered the phenomenon that we term force augmentation. Swine arterial smooth muscle was maximally depolarized with 109 mM K ϩ for 2 min, then submaximally depolarized with 25 mM K ϩ for 28 min, and then maximally depolarized a second time with 109 mM K ϩ for 30 min. The first maximal 109 mM K ϩ depolarization significantly increased crossbridge phosphorylation, the real part of stiffness (GЈ), and stress at 1 min (P Ͻ 0.001, P ϭ 0.002, and P Ͻ 0.001 vs. unstimulated, respectively, stress is force normalized to cross-sectional area). Reduction of activation to 25 mM K ϩ for 28 min reduced crossbridge phosphorylation, GЈ, and stress to intermediate values (all remained significantly increased vs. unstimulated, P ϭ 0.011, P ϭ 0.011, and P Ͻ 0.001, respectively). The second maximal 109 mM K ϩ contraction increased MRLC phosphorylation, GЈ, and stress. Stress 1 min after the second maximal 109 mM K ϩ depolarization (31 min on the time scale) was significantly higher than that observed 1 min after the first 109 mM K ϩ depolarization (P ϭ 0.045; Fig. 1 ). Crossbridge phosphorylation values, measured 20, 40, and 60 s after 109 mM K ϩ depolarization, did not significantly differ when the first contraction was compared with the second contraction ( Fig. 1 , inset at top right). This result suggests that the higher contractile force observed 1 min after the second maximal 109 mM K ϩ depolarization occurred despite similar increases in crossbridge phosphorylation values. Increased force in the second K ϩ contraction despite no significant difference in crossbridge phosphorylation was termed "force augmentation."
RESULTS
Y118 paxillin phosphorylation, noise temperature, hysteresivity, and phase angle were not significantly altered 1 min after the first maximal 109 mM K ϩ depolarization despite the large increases in crossbridge phosphorylation, GЈ, and stress. Y118 paxillin phosphorylation significantly increased while noise temperature and hysteresivity significantly decreased compared with the unstimulated value at all time points after 1 min. Decreased noise temperature and hysteresivity indicate a transition of the muscle to a more "solid" rheology (25) . Y118 paxillin phosphorylation and noise temperature were not significantly altered by the second maximal 109 mM K ϩ depolarization. Noise temperature, hysteresivity, and phase angle were significantly lower 1 min into the second 109 mM K ϩ depolarization (31 min) compared with 1 min into the first 109 mM K ϩ depolarization (1 min, P ϭ 0.002, 0.03, and Ͻ0.001, respectively; Fig. 1 ).
We evaluated whether force augmentation was associated with changes in shortening velocity. Tissues were first depolarized with 109 mM K ϩ for 10 min, then submaximally depolarized with 25 mM K ϩ for 30 min, and then maximally depolarized a second time with 109 mM K ϩ for 10 min (this protocol differs from Fig. 1 in which the first K ϩ depolarization lasted 2 min). Force and shortening velocity were high 1 min into the first 109 mM K ϩ contraction (Fig. 2) . Force was maintained at high levels despite reduced shortening velocity 10 min into the first 109 mM K ϩ contraction (10 min, Fig. 2 ); this is a demonstration of the latch phenomenon (3). Force and shortening velocity fell to lower values when the tissues were submaximally depolarized with 25 mM K ϩ (22 and 31 min, Fig. 2 ). With the second 109 mM K ϩ depolarization, there was an increase in shortening velocity similar to that observed with the first 109 mM K ϩ depolarization; however, the initial contraction in the second 109 mM K ϩ depolarization was larger than that observed with the first 109 mM K ϩ depolarization (41 min, Fig. 2 ). This suggests that an increase in shortening velocity did not cause the higher force in the second 109 mM K ϩ depolarization, i.e., the force augmentation. Since increases in crossbridge phosphorylation ( Fig. 1 ) and shortening velocity (Fig. 2 ) during the 109 mM K ϩ depolarization were not responsible for force augmentation, we thought it possible that other biochemical conditions present before the second 109 mM K ϩ depolarization could determine force augmentation. Values of crossbridge phosphorylation, Y118 paxillin phosphorylation, and stress were all significantly Fig. 2 . Velocity and force during a force augmentation protocol shows no increase in shortening velocity despite higher force during the second, forceaugmented 109 mM K ϩ contraction. Tissues were first depolarized at 0 min with 109 mM K ϩ , then submaximally depolarized at 10 min with 25 mM K ϩ , and then maximally depolarized a second time at 40 min with 109 mM K ϩ . Velocity was measured at a light (10%) and a more heavy (40%) load (top) along with isometric force before the release (bottom, velocity could not be measured at 0 min when force was low). Data are shown as means Ϯ SE with n ϭ 7 (some errors are smaller than the symbols). The dashed-dotted lines represent the values at 10 min and show an increase in force (force augmentation) at 41 min without an increase in shortening velocity. Lo, optimal length. 10 5 N/m 2 , filled symbols, bottom). Differences were tested by Fisher least significant difference (LSD) test post ANOVA. #P Ͻ 0.05 compared with all values taken after 1 min; *P Ͻ 0.05 when comparing the 1-min data with the 31-min data (for phase angle, the zero value was significantly different from all values after 1 min with the exception of the value at 31 min). The dasheddotted lines represent the values at 3 min and show force augmentation, i.e., the significantly higher force in the second 109 mM K ϩ contraction (at 31 min) as compared with the first 109 mM K ϩ contraction (at 1 min). The inset at top right compares the crossbridge phosphorylation transients (measured at 0, 20, 40, and 60 s after depolarization with 109 mM K ϩ , @Significant differences in crossbridge phosphorylation between the first and second 109 mM K ϩ depolarizations). The larger second contraction, which we term "force augmentation," 1) occurred despite no significant difference in the crossbridge phosphorylation transient (see inset at top right) and 2) was associated with higher prior values of Y118 paxillin phosphorylation and lower prior values of noise temperature, hysteresivity, and phase angle (compare 0 vs. 30 min). These data suggest an association between the larger contraction (force augmentation) and the prior higher Y118 paxillin phosphorylation with lower noise temperature, hysteresivity, and phase angle (indicating transition to a more solid rheology).
higher and noise temperature, hysteresivity, and phase angle were all significantly lower before the second, larger force augmented 109 mM K ϩ contraction at 30 min when compared with the values before the first 109 mM K ϩ contraction at 0 min ( Fig. 1 , P ϭ 0.001, 0.012, 0.005, Ͻ0.001, Ͻ0.001, and Ͻ0.001, respectively). These data suggest that the higher crossbridge phosphorylation, the higher Y118 paxillin phosphorylation, the lower noise temperature, the lower hysteresivity, the lower phase angle, and/or the higher stress before the second 109 mM K ϩ depolarization correlated with the force augmentation observed with the second 109 mM K ϩ depolarization.
On the basis of these biochemical and mechanical differences, we hypothesized that Y118 paxillin phosphorylationinduced stimulated actin polymerization and the resultant change to a more solid rheology (low noise temperature) present during the submaximal 25 mM K ϩ depolarization (at 30 min in Fig. 1) were responsible for the subsequent force augmentation. We therefore tested whether the degree of submaximal K ϩ activation was associated with the relative amount of subsequent force augmentation. Swine carotid artery segments were contracted nine times with 109 mM K ϩ for 10 min. These nine contractions were preceded by a 30 The degree of force augmentation depended on the concentration of the K ϩ in the 30-min partial depolarization before each maximal 109 mM K ϩ contraction (Fig. 4, bottom) . Increasing levels of force augmentation were seen with increasing concentrations of K ϩ pretreatment (P ϭ 0.005, Ͻ0.001, and Ͻ0.001, respectively for 20, 25, and 30 mM K ϩ ), but not with 15 mM K ϩ pretreatment. Increasing the concentration of K ϩ in the 30-min pretreatment was associated with proportionally increased Y118 paxillin phosphorylation, increased Factin, decreased noise temperature, decreased phase angle, and increased prior stress (Fig. 4) . Y118 paxillin phosphorylation was significantly increased only with 30 mM K ϩ pretreatment when tested by ANOVA (20 mM K ϩ pretreatment was significantly higher than control by paired t-test, P Ͻ 0.05). There was an increase in the relative amount of F-actin with 25 mM K ϩ pretreatment when compared with control (P Ͻ 0.001). Noise temperature was significantly decreased when tissues were pretreated with 20, 25, or 30 mM K ϩ (P ϭ 0.015, Ͻ0.001, and Ͻ0.001, respectively), as was phase angle (P ϭ 0.045, 0.01 and 0.005, respectively). These data suggest that the concentration of K ϩ in the partial depolarization solution determined the level of Y118 paxillin phosphorylation, F-actin, and the transition to a solid rheology (lower noise temperature and phase angle) in a graded manner. Prior stress was also significantly increased when tissues were pretreated with 25 or 30 mM K ϩ (P Ͻ 0.001 for both, compared with rest), as expected.
In individual tissues frozen for Y118 paxillin phosphorylation, force augmentation significantly and positively correlated with the level of Y118 paxillin phosphorylation present before maximal depolarization (r 2 ϭ 0.35, Fig. 5A ). In a comparison of mean force augmentation in the tissues frozen for paxillin phosphorylation to similarly treated tissues frozen for F-actin, Fig. 3 . Representative force tracing from a force augmentation experiment. We performed nine sequential 10-min-long 109 mM K ϩ contractions that each followed a 30-min incubation in either normal physiological saline solution (PSS), 4.7 mM K ϩ , contractions 1, 3, 5, and 7) or submaximal K ϩ (20 mM contraction 2, 25 mM contraction 4, 30 mM contraction 6, and 15 mM contraction 8). Each 109 mM K ϩ contraction that followed a submaximal K ϩ treatment (even-numbered contractions) was both preceded and followed by control contractions (odd-numbered contractions). Prior 20, 25, and 30 mM K ϩ depolarization resulted in a higher force during the subsequent maximal 109 mM K ϩ contraction, i.e., force augmentation. The vertical perturbations before and during each contraction indicate times at which data were collected for noise temperature, stress, and stiffness, with sinusoidal length changes at varying frequencies (0.3, 1, 3, 10, and 30 Hz). (The authors have traced over the chart recorder lines to make the lines more readable.)
force augmentation significantly and positively correlated with F-actin present before maximal depolarization (r 2 ϭ 0.93, Fig,  5B ). In individual tissues evaluated for mechanical characteristics, force augmentation negatively and significantly correlated with the level of noise temperature present before maximal depolarization (r 2 ϭ 0.63, Fig. 5C ). These data suggest that the degree of force augmentation correlated with prior Y118 paxillin phosphorylation, prior F-actin, and prior solid rheology, i.e., force augmentation occurred at a lower prior noise temperature.
The above experiments did not discriminate which of the measured biochemical conditions present before 109 mM K ϩ depolarization determined force augmentation. It is possible that either 1) increased prior crossbridge phosphorylation or the prior contraction caused force augmentation or 2) stimulated actin polymerization (increased Y118 paxillin phosphorylation, increased F-actin, and lower noise temperature) caused force augmentation. As part of an unpublished study to determine how rheology is regulated in smooth muscle, we found that readdition of Ca 2ϩ to Ca 2ϩ -depleted tissues induced a partial contraction that was not associated with reductions in noise temperature. This protocol allowed us to test whether force augmentation is observed after a prior partial contraction that was not associated with stimulated actin polymerization. ϩ incubation. The data show increased force augmentation with higher prior Y118 paxillin phosphorylation, higher prior F-actin content, lower prior noise temperature, lower prior phase angle, and higher prior stress. The dot-dashed line in the prior stress panel is for comparison with Fig. 6 ; see text.
Maximal depolarization of swine arterial smooth muscle with 109 mM K ϩ for 10 min induced a rapid increase in crossbridge phosphorylation and contraction, a slow increase in Y118 paxillin phosphorylation, and a slow decrease in noise temperature (Fig. 6) . Reduction in extracellular Ca 2ϩ gradually to Ͻ10 nM in the continued presence of 109 mM K ϩ reduced crossbridge phosphorylation and contractile force, reduced Y118 paxillin phosphorylation, and increased noise temperature to near basal levels. At 100 min, extracellular Ca 2ϩ was restored to 1.6 mM and K ϩ was reduced to 4.7 mM, inducing a partial contraction that was not associated with a significant increase in Y118 paxillin phosphorylation or a significant reduction in noise temperature (measured at 105 min in Fig. 6 ). At 105 min, tissues were maximally depolarized a second time with 109 mM K ϩ , inducing a contraction that was similar to the first K ϩ contraction, i.e., there was no force augmentation. Crossbridge phosphorylation values, measured 20, 40, and 60 s after 109 mM K ϩ depolarization, did not significantly differ when the first contraction was compared with the second contraction (Fig. 6, inset at top right) . This result suggests that the absence of a significant change in Y118 paxillin phosphorylation and noise temperature at 105 min was associated with the absence of subsequent force augmentation, i.e., the contraction was that expected by the increase in crossbridge phosphorylation values. Note that the force induced by readdition of Ca 2ϩ to Ca 2ϩ depleted tissues (105 min at the vertical dotted line in Fig. 6 ) was higher than that induced by 20 mM K ϩ , a pretreatment that was associated with force augmentation (see Fig. 4 where the prior force induced by readdition of Ca 2ϩ to Ca 2ϩ -depleted tissues is shown as the dot-dashed line in the prior stress panel). These data suggest that force augmentation is predicted by stimulated actin polymerization (increased Y118 paxillin phosphorylation, increased F-actin, and lower noise temperature) and not by increased prior force or crossbridge phosphorylation.
DISCUSSION
Force augmentation occurs with prior stimulated actin polymerization. Force augmentation is a newly described phenomenon in which K ϩ -induced partial contraction of arterial smooth muscle tissue results in higher force generation during a subsequent maximal contraction (Figs. 1-4) . Differences in the crossbridge phosphorylation or shortening velocity transient were not seen during force augmentation (Fig. 1, inset, and Fig. 2 ), suggesting that increased crossbridge cycling rates are not responsible for force augmentation. The degree of force augmentation increased proportionally with the concentration of K ϩ in the buffer before the subsequent maximal contraction (Figs. 3 and 4) , suggesting that conditions before the maximal stimulation were responsible for force augmentation. The degree of force augmentation increased proportionally with measures of prior stimulus-induced actin polymerization (Y118 paxillin phosphorylation, F-actin, and noise temperature, Fig.  5 ). Force augmentation was not observed when tissues were partially contracted in a protocol that did not induce stimulated actin polymerization (Fig. 6 ). These data support the hypothesis that force augmentation is caused by prior stimulated actin polymerization, i.e., by increased Y118 paxillin phosphorylation, increased F-actin, and transition to a more solid rheology (a lower noise temperature, hysteresivity, and phase angle).
There are two potential mechanisms for force augmentation: 1) crossbridge interactions could be more efficient when actin is more polymerized, allowing greater force generation and/or 2) polymerized actin, per se, could contribute to force independent of crossbridge interactions. We think that the former is most likely; however, differentiation of these two mechanisms will need to be addressed in a future study.
Force augmentation, as we describe in this study, differs from the phenomena termed "force potentiation." Force potentiation was defined as increased airway smooth muscle contraction induced by oscillatory changes in length. Seow (28) found that relatively large length changes (Ͼ0.15 L o ) altered the length tension relationship and that oscillatory changes in length (0.1-0.25 L o at 4.2 Hz) increased force. Wang et al. (30) found similar force potentiation with oscillatory length changes in airway smooth muscle. Both groups found that oscillations could also decrease force. Potential mechanisms for oscilla- to Ca 2ϩ -depleted tissues does not induce force augmentation in swine carotid. Tissues were maximally depolarized with 109 mM K ϩ from 1 to 10 min, then extracellular Ca 2ϩ was reduced to 0.15 mM from 10 to 40 min, to nominally zero (no added Ca 2ϩ ) from 40 to 70 min, and to Ͻ10 nM (with 1 mM EGTA) from 70 to 100 min, all in the presence of 109 mM K ϩ . At 100 min, extracellular Ca 2ϩ was restored to 1.6 mM and K ϩ was reduced to 4.7 mM, inducing a partial contraction that was not associated with a reduction in noise temperature. At 105 min (vertical dotted line), tissues were maximally depolarized a second time with 109 mM K ϩ , inducing a contraction similar to the first K ϩ contraction, i.e., there was no force augmentation. All data are plotted as means Ϯ SE with n ϭ 4 -6. Shown are crossbridge phosphorylation (top), Y118 paxillin phosphorylation (second from top), noise temperature (third from top), and stress (bottom). Differences were tested by Fisher LSD test post ANOVA. #P Ͻ 0.05 compared with rest (0 min). The inset at top right compares the crossbridge phosphorylation transients (measured at 0, 20, 40, and 60 s after depolarization with 109 mM K ϩ ). There was no significant difference in measured crossbridge phosphorylation between the first and second 109 mM K ϩ depolarizations. The second contraction did not show force augmentation, despite 1) higher prior force, 2) similar changes in crossbridge phosphorylation (see inset at top right), and 3) resting values of noise temperature (compare 0 vs. 105 min). These data suggest that 1) partial activation observed with readdition of extracellular Ca 2ϩ was not sufficient to cause force augmentation and 2) force augmentation was not observed in the absence of higher Y118 paxillin phosphorylation or lower noise temperature.
tion-induced force potentiation include cytoskeletal changes as proposed by Ford (7) and Gunst and Fredberg (8) . It should be noted that in 1990, we found that a 1-Hz oscillatory length change reduced contractility in swine carotid artery (22) . Importantly, our current description of force augmentation does not involve a change in tissue length; we find that partial activation without a change in length augments force by 15% (Fig. 1) , a process we term force augmentation.
The low Ca 2ϩ protocol employed in Fig. 6 will clearly have major effects on intracellular Ca 2ϩ pools which can have significant effects on contractility (19, 26) . However, these effects should not impact the overall implications of the low Ca 2ϩ protocol. Regardless of the changes in Ca 2ϩ pools, we found that a partial contraction without significant changes in Y118 paxillin phosphorylation or noise temperature did not induce force augmentation upon subsequent maximal depolarization (Fig. 6, 105 min) . This suggests that the contraction was that expected by the increase in crossbridge phosphorylation values alone when there were no prior changes in Y118 paxillin phosphorylation and noise temperature.
The latchbridge hypothesis, stimulated actin polymerization, and force augmentation. It is well accepted that crossbridge phosphorylation is important in arterial smooth muscle contraction: maximal stimulation of arterial smooth muscle typically produces large increases in crossbridge phosphorylation and shortening velocity that precede the contraction (reviewed in Ref. 15) . During the sustained phase of a maximal contraction, crossbridge phosphorylation and shortening velocity typically fall to intermediate levels while force is maintained at near peak levels, a phenomenon termed the "latch phenomenon" (Fig. 2 and Refs. 3 and 20). Murphy's latchbridge hypothesis sought to explain the latch phenomenon by postulating 1) that crossbridge phosphorylation, per se, is the only regulator of force and 2) the existence of "latchbridges," which are attached force maintaining crossbridges formed by dephosphorylation of attached phosphorylated crossbridges (9) . If latchbridges are hypothesized to detach four to five times slower than phosphorylated crossbridges, a quantitative model of contraction predicted force as a function of crossbridge phosphorylation. Unfortunately, it has been difficult to experimentally show the existence of latchbridges and whether latchbridges detach slower than phosphorylated crossbridges. Since we observed an increase in force without a significant increase in crossbridge phosphorylation (Fig. 1) or shortening velocity (Fig. 2) , our data suggest that Murphy's latchbridge hypothesis cannot explain force augmentation.
We previously showed that the time courses of Y118 paxillin phosphorylation, actin polymerization, and transition to a solid rheology were slower than the time course of a 109 mM K ϩ contraction, suggesting that 1) the initial phase of a 109 mM K ϩ contraction was caused by increased crossbridge phosphorylation and not by stimulus-induced actin polymerization and 2) an increase in Y118 paxillin phosphorylation, increase in actin polymerization, and transition to a more solid rheology could be responsible for force maintenance with reduced crossbridge phosphorylation during the sustained phase of a 109 mM K ϩ contraction, i.e., the latch phenomenon (25) . Stimulated actin polymerization could provide a mechanism for a unifying hypothesis to explain both the latch phenomenon and force augmentation. In Fig. 7 , we present a potential schema to demonstrate such a unifying hypothesis. If we postulate that 1) contractile force is proportional to crossbridge phosphorylation in the absence of changes in actin polymerization and 2) increases in actin polymerization increase the contractile force beyond that expected by increases in crossbridge phosphorylation per se (without detailing the exact mechanism how this occurs), then we propose the following: An unstimulated artery would have a low resting force and no stimulated actin polymerization (labeled 1 in Fig. 7A) . A typical maximal 109 mM K ϩ depolarization would induce a rapid initial increase in force associated with the rapid increase in crossbridge phosphorylation without stimulated actin polymerization (labeled 2 in Fig. 7A ). As crossbridge phosphorylation and shortening velocity fell during the sustained contraction, force would be maintained (i.e., latch) by stimulated actin polymerization (labeled 3 in Fig. 7A ).
To show a force augmented contraction, a tissue would be partially activated with K ϩ and have a partial contraction with stimulated actin polymerization (labeled 4 in Fig. 7B ). Depolarization with 109 mM K ϩ would induce a rapid initial increase in force associated with the rapid increase in crossbridge phosphorylation. This force would be higher than in Fig.  7A since stimulated actin polymerization had already occurred before the maximal contraction; this results in an "augmented" initial phase of the contraction (labeled 5 in Fig. 7B ). As crossbridge phosphorylation and shortening velocity fall during the sustained contraction, force would fall in a linear Fig. 7 . Schema of a normal contraction (A), a contraction with force augmentation (B), and a contraction when stimulated actin polymerization is blocked (C). In this postulated mechanism, force that is caused by changes in crossbridge phosphorylation is shown in the horizontal lightly shaded regions (marked XB phos). Force that is higher with stimulated actin polymerization is shown in the crosshatched darkly shaded regions (marked Actin; note that this does not imply that actin per se is producing force, since it is possible that increased actin polymerization could allow more crossbridge mediated force). A: force maintenance during a normal contraction occurs because stimulated actin polymerization "takes over" for the falling crossbridge phosphorylation during the sustained contraction to keep force high. B: force augmentation occurs when actin polymerization is elevated before and during the maximal contraction, thereby increasing the initial phase of contraction. C: inhibition of stimulated actin polymerization would result in force following crossbridge phosphorylation so that force is not maintained. The numbered labels refer to the text. fashion; it would not be maintained since actin polymerization remains high throughout the contraction (labeled 6 in Fig. 7B) .
If we had a treatment that blocked stimulated actin polymerization, then an unstimulated artery would have a low resting force and no stimulated actin polymerization (labeled 7 in Fig.  7C) . A typical maximal 109 mM K ϩ depolarization would induce a rapid initial increase in force associated with the rapid increase in crossbridge phosphorylation without stimulated actin polymerization (labeled 8 in Fig. 7C ). Since stimulated actin polymerization would be blocked, force would fall during the sustained contraction as crossbridge phosphorylation fell, i.e., there would be no latch phenomenon (labeled 9 in Fig. 7C ). Note that force augmentation (Fig. 7B) and inhibition of stimulated actin polymerization (Fig. 7C) both have a similar pattern exhibiting no "force maintenance"; the difference is whether the initial phase of force is increased with force augmentation (Fig. 7B) or the force maintenance phase is reduced with inhibited actin polymerization (Fig. 7C) . Note that our data also support the existence of latchbridges to explain the reduction in shortening velocity during the sustained phase of both normal and force augmented contractions (10 and 50 min in Fig. 2 ). Further study is required to sort out the mechanism responsible for the latch phenomenon.
Significance of force augmentation. It may appear that the magnitude of force augmentation is relatively small since force is increased by only 15% over a nonaugmented contraction; however, a 15% increase in force can have a large effect on arterial flow. In accordance with the length-tension relationship of smooth muscle, a 15% increase in contractile force would cause the arterial length to decrease to 0.81 L o , assuming no change in the other key parameters. If starting length were 0.9 L o or 1.0 L o , then the circumference (and radius) would shorten by 9% or 19%, respectively, to get to 0.81 L o . Assuming Hagan-Poiseuille flow, wherein flow (Q) is a function of radius (r), pressure drop (⌬P), viscosity (), and tube length (L), we have that Q ϭ r 4 ⌬P/8 L. If the other parameters do not change, a 9% to 19% reduction in radius corresponds to a 31% to 57% reduction in flow. We expect that this reduction in flow would cause downstream ischemia and result in reflexes to reduce arterial contractility and partially restore normal flow. Additionally, the increased contraction occurring with force augmentation is an example of a mechanism with "feed-forward" characteristics. These considerations suggest that force augmentation could result in significant decreases in arterial diameter, compounding clinical conditions such as malignant hypertension and/or vasospasm.
